Frankfurt - Delayed Quote EUR
Chemomab Therapeutics Ltd. (2QV0.F)
1.0900
+0.0300
+(2.83%)
At close: April 25 at 3:29:01 PM GMT+2
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Cash Flow
-15,386
-15,386
-23,611
-20,370
-12,374
Investing Cash Flow
2,297
2,297
15,879
19,533
-45,186
Financing Cash Flow
9,868
9,868
3,504
-808
61,074
End Cash Position
6,147
6,147
9,368
13,596
15,241
Income Tax Paid Supplemental Data
--
--
--
5
--
Capital Expenditure
--
--
-3
-68
-239
Issuance of Capital Stock
9,868
9,868
3,504
267
58,637
Repurchase of Capital Stock
--
--
--
-1,218
--
Free Cash Flow
-15,386
-15,386
-23,614
-20,438
-12,613
12/31/2021 - 5/19/2021
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
PBN.F Alterity Therapeutics Limited
0.0045
+12.50%
6XY.F HBM Holdings Limited
0.9000
+5.88%
FAB.L Fusion Antibodies plc
6.80
-9.09%
TRMED.OL Thor Medical ASA
2.4000
-2.24%
ELIC.ST Elicera Therapeutics AB (publ)
4.3500
+13.73%
FARN.L Faron Pharmaceuticals Oy
202.00
-0.25%
BIOVIC-B.ST Biovica International AB (publ)
0.6980
+9.06%
MEDCL.PA MedinCell S.A.
14.97
+0.13%
VVY.AS Vivoryon Therapeutics N.V.
1.7760
-1.88%
MDCLF MedinCell S.A.
6.98
0.00%